Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Abdulmelik Aytatli"'
Autor:
Omer Faruk Karatas, Seyma Teber, Ahmet Yilmaz, Asli Baltacioglu, Selinay Merve Kilic, Emel Poyraz, Abdulmelik Aytatli, Sumeyye Ozturk, Ayse Varol
Publikováno v:
Trakya University Journal of Natural Sciences, Vol 19, Iss 2, Pp 197-207 (2018)
Tongue squamous cell carcinoma (TSCC) is known to be the most malignant cancer type amongst other oral cancers with increasing incidence and mortality rates in the past five years. Since the life expectancy for TSCC patients is limited and the curren
Externí odkaz:
https://doaj.org/article/158153db83b84f86a0fb98ccbfd7e2ed
Publikováno v:
RSC Medicinal Chemistry.
Modulation of existing drugs is an attractive strategy to achieve improved activity in cancer therapy by lowering their effective dose. Preparation of relatives has been suggested and explored to improve...
Autor:
Michael Ittmann, Neslisah Barlak, Betul Gundogdu, Omer Faruk Karatas, Abdulmelik Aytatli, Hasan Onur Caglar, Arzu Tatar, Fatma Sanli
Publikováno v:
Cellular Oncology. 45:41-56
Development of chemoresistance is one of the major obstacles to the treatment of head and neck squamous cell carcinoma (HNSCC). The PI3K/Akt pathway, involved in drug resistance, has been found to be overactivated in > 90% of HNSCCs. Aberrant activat
Autor:
Elanur Aydin Karatas, Omer Faruk Karatas, Fatma Sanli, Serkan Ortucu, Abdulmelik Aytatli, Neslisah Barlak, Ozel Capik, Ahsen Kilic, Aysenur Yazici
Publikováno v:
Cell Biology International. 45:1082-1090
Prostate cancer (PCa) is one of the most prevalent cancer types among males. Differential expression of microRNAs is associated with various cancers including PCa. Although mature microRNAs are preferentially located in the cytoplasm, several studies
Autor:
Ahsen Kilinç, Fatma Sanli, Neslisah Barlak, Ozel Capik, Omer Faruk Karatas, Abdulmelik Aytatli
Publikováno v:
Volume: 6, Issue: 5 380-387
The European Research Journal
The European Research Journal
Objectives: Larynx cancer (LCa) represents approximately 30% of all cancers seen in the head and neck region, with an unchanged overall survival rate over the last decades. Although several novel diagnostic and therapeutic options has been developed,
Autor:
Neslisah Barlak, Omer Faruk Karatas, Ozel Capik, Abdulmelik Aytatli, Fatma Sanli, Ahsen Kilic
Publikováno v:
The Laryngoscope. 130:2818-2824
Objectives In this study, we aimed at investigating the expressions of miR-145 and its well-characterized direct targets on carboplatin treatment. Study design Laboratory study. Methods The effect of carboplatin and miR-145 on the proliferative capac
Autor:
Michael Ittmann, Serkan Ortucu, Omer Faruk Karatas, Neslisah Barlak, Ozel Capik, Fatma Sanli, Abdulmelik Aytatli, Aysenur Yazici, Ahsen Kilic
Publikováno v:
Cell biology international.
Prostate cancer (PCa) is one of the most common types of cancer in men. In several recent studies, chromosomal deletions in the q arm of chromosome 2, where ING5 resides within, have been identified in various cancer types including PCa. In this stud
Autor:
Selinay Merve Kilic, Abdulmelik Aytatli, Ahmet Yilmaz, Ayse Varol, Asli Baltacioglu, Seyma Teber, Emel Poyraz, Sumeyye Ozturk, Omer Faruk Karatas
Publikováno v:
Volume: 19, Issue: 2 197-207
Trakya University Journal of Natural Sciences
Trakya University Journal of Natural Sciences, Vol 19, Iss 2, Pp 197-207 (2018)
Trakya University Journal of Natural Sciences
Trakya University Journal of Natural Sciences, Vol 19, Iss 2, Pp 197-207 (2018)
Dilskuamöz hücreli karsinomu (DSHK) son 5 yılda artan insidans ve mortaliteoranları ile birlikte diğer ağız içi kanserleri arasında en kötü huylu kansertipi olarak bilinmektedir. DSHK hastalarının yaşam süreleri sınırlı olduğundanv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9b0e23d600bfbc935bf4bf5d296bc0d
https://dergipark.org.tr/tr/pub/trkjnat/issue/39729/368829
https://dergipark.org.tr/tr/pub/trkjnat/issue/39729/368829
Autor:
Aytatli, Abdulmelik1,2 (AUTHOR), Barlak, Neslisah1,2 (AUTHOR), Sanli, Fatma1,2 (AUTHOR), Caglar, Hasan Onur1 (AUTHOR), Gundogdu, Betul3 (AUTHOR), Tatar, Arzu4 (AUTHOR), Ittmann, Michael5,6 (AUTHOR), Karatas, Omer Faruk1,2 (AUTHOR) faruk.karatas@erzurum.edu.tr
Publikováno v:
Cellular Oncology (2211-3428). Feb2022, Vol. 45 Issue 1, p41-56. 16p.
Publikováno v:
RSC Medicinal Chemistry; Jul2023, Vol. 14 Issue 7, p1203-1207, 5p